Clinical Trials Logo
  1. Home
  2. Takayasu Arteritis
  3. NCT06289738
  4. Details
NCT06289738 Clinical Trial

ICF in Takayasu Arteritis

Takayasu Arteritis Clinical Trial

Official title:
Problem Analysis Based on the International Classification of Functioning, Disability and Health in Patients With Takayasu Arteritis

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06289738
Other study ID # ICF in Takayasu Arteritis
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 21, 2024
Est. completion date March 25, 2024

Study information
Verified date May 2024
Source Pamukkale University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim was to analyze the problem in patients with Takayasu Arteritis based on the International Classification of Functioning, Disability and Health.The sample of our study will consist of individuals between the ages of 18-65 who have been diagnosed with Takayasu Arteritis by rheumatologists and are followed by Pamukkale University Rheumatology Clinic.

Recruitment information / eligibility
Status Completed
Enrollment 15
Est. completion date March 25, 2024
Est. primary completion date March 20, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:-Being between the ages of 18-65 - Volunteering to participate in the study - Being diagnosed with Takayasu Arteritis by a rheumatologist Exclusion Criteria:- Having another disease that affects your physical condition - Having cognitive impairment that makes it difficult to cooperate - Being pregnant - Having a neurological disease - Having had any surgery in the last year - Having another concurrent rheumatic disease

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• ICF
Matching the answers given to the question set consisting of 6 open-ended questions with ICF

Locations
Country Name City State
Turkey Elif Gur Kabul Usak

Sponsors (1)
Lead Sponsor Collaborator
Pamukkale University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary 6 open-ended questions ICF 25 minutes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04564001 - Multicentre, Randomized, Prospective Trial Evaluating the Efficacy and Safety of Infliximab to Tocilizumab in Refractory or Relapsing Takayasu Arteritis Phase 2
Terminated NCT04882072 - A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK) Phase 3
Completed NCT03750929 - Aerobic Capacity and Strength Exercise in Takayasu's Arteritis N/A
Recruiting NCT04137614 - Drug-coated Balloon for Takayasu Arteritis Associated Renal Artery Stenosis N/A
Recruiting NCT02967068 - VCRC Tissue Repository
Recruiting NCT05102448 - Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis Phase 4
Recruiting NCT03893136 - The Registry Study of Takayasu Arteritis in East China
Active, not recruiting NCT00006055 - Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases N/A
Completed NCT03096275 - Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis Phase 3
Recruiting NCT04299971 - Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients Phase 4
Recruiting NCT04300686 - A Pilot Study in Severe Patients With Takayasu Arteritis. Phase 4
Recruiting NCT03192878 - Infliximab Biosimilar in Takayasu's Arteritis N/A
Active, not recruiting NCT04071691 - PET Imaging of Giant Cell and Takayasu Arteritis
Recruiting NCT05904301 - Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases
Completed NCT02101333 - Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis Phase 3
Not yet recruiting NCT03550781 - Anti-inflammatory Treatment for Inactive Takayasu Arteritis Phase 2/Phase 3
Active, not recruiting NCT05168475 - Biologics in Refractory Vasculitis Phase 2
Completed NCT03956394 - Takayasu Arteritis Activity Evaluation by Ultrafast Ultrasound Imaging N/A
Recruiting NCT05151848 - Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis Phase 4
Completed NCT03430388 - Yellow Fever Vaccine in Patients With Rheumatic Diseases N/A